• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

To study immune histochemical expression of CD34 and CD117 in benign and malignant prostaticlesions

    Dr. Asha Jyothi. T, Dr. C. Aruna

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 7-20

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

ToevaluateandcomparetheexpressionpatternsofCD34andCD117inbenignandmalignantp
rostatictissuesandtheirrelationtotheclinicopathologicalfeatures.
Methodology:The present study has been conducted at Department of Pathology,
atOsmaniaGeneralHospitalfromAugust2017toJuly2019.total100caseswerecollected.Rout
ineprocessingandHaematoxylinandEosinstainingofreceivedspecimensweredonefollowed
byimmunohistochemicalanalysiswithCD34andCD117.
Keywords:
    CD34 CD17 Prostate Cancer Westernblotting PCa Gleasonscore malignant lesions
  • PDF (534 K)
  • XML
(2022). To study immune histochemical expression of CD34 and CD117 in benign and malignant prostaticlesions. European Journal of Molecular & Clinical Medicine, 9(3), 7-20.
Dr. Asha Jyothi. T, Dr. C. Aruna. "To study immune histochemical expression of CD34 and CD117 in benign and malignant prostaticlesions". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 7-20.
(2022). 'To study immune histochemical expression of CD34 and CD117 in benign and malignant prostaticlesions', European Journal of Molecular & Clinical Medicine, 9(3), pp. 7-20.
To study immune histochemical expression of CD34 and CD117 in benign and malignant prostaticlesions. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 7-20.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 886
  • PDF Download: 270
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus